summa tirzepatide Semaglutide and are both injectable medications used in medical weight management—but they act on different metabolic pathways, which is why patient selection matters. Semaglutide (GLP-1 receptor agonist): • Primarily targets appetite Learn more about Tirzepatide_Industry News_Senova

Think green tea, fatty fish, cucumbers, asparagus, kimchi, kombucha, leafy greens, and oats

Pemmaraju N, Kremyanskaya M, Kuykendall A, Ritchie E, Gotlib J, Gerds A, et al

Tirzepatide is also approved as Mounjaro in some countries outside the U.S

10.3389/fphys.2018.01622 Summary Keywords dipeptidyl peptidase-4, glucagon-like peptide-1, incretin, peptide degradation, therapy, type 2 diabetes Citation Deacon CF (2019) Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes

These medications cut off the intuitive feeling of what we need and when, which is incredibly dysregulating and very dangerous for patients with psychiatric disorders. Dr Lorna Richards , Priory consultant psychiatrist, agrees, adding that side effects like nausea, vomiting and abdominal pain further disrupt regulated eating patterns, which are the mainstay treatment for eating disorders. From prescription drug to lifestyle product Alongside under-supported medical use, another shift is underway: GLP-1s slipping into lifestyle territory